Centiva Capital, LP Biomarin Pharmaceutical Inc Transaction History

Centiva Capital, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $220,420 - $260,370	2,630 New	2,630 $229,000
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $21,756 - $25,175	251 Added 12.01%	2,341 $202,000
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $1.84 Million - $2.46 Million	-20,985 Reduced 90.94%	2,090 $203,000
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $798,212 - $1.07 Million	-9,863 Reduced 29.94%	23,075 $2.39 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $224,132 - $264,452	2,728 Added 9.03%	32,938 $2.79 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $318,800 - $387,351	4,460 Added 17.32%	30,210 $2.5 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $1.91 Million - $2.39 Million	25,750 New	25,750 $1.99 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $2.1 Million - $2.68 Million	-29,301 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $584,477 - $668,118	-7,817 Reduced 21.06%	29,301 $2.26 Million
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $323,786 - $363,579	-4,288 Reduced 10.36%	37,118 $3.1 Million
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $829,951 - $1.01 Million	11,106 Added 36.65%	41,406 $3.13 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $2.2 Million - $2.73 Million	30,300 New	30,300 $2.66 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $171,073 - $232,149	-2,397 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $154,055 - $207,028	2,397 New	2,397 $203,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.